Reader View AI Reader View Incyte stock price target maintained at $152 by H.C. Wainwright on cancer drug data www.investing.com · October 27, 2026 · 12:12 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link